-
New clients, overall growth boosts Accredo's Q4
MEMPHIS — Sales at specialty pharmacy provider Accredo Health Group for the fourth quarter grew to $3 billion, a 21.3% increase over fourth quarter 2009, according to parent company Medco Health Solutions.
Sales for the year were $11.3 billion, a 19.1% increase over 2009. The company said the growth was the result of new clients and growth across the specialty business.
Growth in sales helped drive operating income for the quarter up by 30.7% to $109.9 million, while operating income for the full year increased by 22.7% to $438.2 million.
-
Gilead to acquire Calistoga
FOSTER CITY, Calif. — Drug maker Gilead Sciences plans to buy out a privately owned Seattle company that makes treatments for cancer and inflammatory diseases, Gilead said Tuesday.
The Foster City, Calif.-based company will buy Calistoga Pharmaceuticals for $375 million, plus additional milestone payments of up to $225 million.